Concepedia

Franklin Liu

FL

17

Publications

2.4K

Citations

16

H-Index

1996

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

United States Military Academy

Memorial Sloan Kettering Cancer Center

Diabetes Australia

Target (United States)

Franklin Liu is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, health sciences, and cell signaling.

Top concepts

MedicineHealthPharmacologyCell SignalingDiabetesPhysiologyBiochemistryMetabolic SyndromeSignal TransductionCell Biology

Publications per year

1996–2019

17

Publications

17

Glucagon-Like Peptide 1/Glucagon Receptor Dual Agonism Reverses Obesity in Mice

Alessandro Pocai, Paul E. Carrington, Jennifer R. Adams et al. · Diabetes · 2009 · 405 citations · Full text

Mice lacking dipeptidyl peptidase IV are protected against obesity and insulin resistance

Stacey Conarello, Zhihua Li, John Ronan et al. · Proceedings of the National Academy of Sciences · 2003 · 348 citations · Full text

Systemic pan-AMPK activator MK-8722 improves glucose homeostasis but induces cardiac hypertrophy

Robert W. Myers, Hong-Ping Guan, Juliann Ehrhart et al. · Science · 2017 · 329 citations

Cardiac Muscle, Cardiovascular Pharmacology, Glucose Homeostasis +23

Prevention of obesity in mice by antisense oligonucleotide inhibitors of stearoyl-CoA desaturase–1

Guoqiang Jiang, Zhihua Li, Franklin Liu et al. · Journal of Clinical Investigation · 2005 · 255 citations · Full text

Pharmacotherapy, Fatty Liver Disease, Obesity +20

Prevention of obesity in mice by antisense oligonucleotide inhibitors of stearoyl-CoA desaturase–1

Guoqiang Jiang, Zhihua Li, Franklin Liu et al. · Journal of Clinical Investigation · 2005 · 236 citations

Pharmacotherapy, Fatty Liver Disease, Caloric Restriction +22

Rows per page

1–5 of 17